Sleep Apnea Clinical Trial
When a disorder is as prevalent as sleep apnea hypopnea syndrome various medical levels and strategies should be implicated. We to evaluate the degree of concordance in management between a sleep reference centre and non-reference centres.
INTRODUCTION: When a disorder is as prevalent as SAHS, different medical levels should be
involved to facilitate diagnosis for all patients, or at least those that are in
moderate-severe or risk groups. A good option could be to transfer the patient assessment to
non-reference centres (NRC). Therefore, the aim of the present study was to evaluate this
strategy by analysing the degree of concordance between RC and NRC in treatment decision and
management of SAHS patients.
MATERIALS AND METHODS: Study subjects: The study population consisted of 88 consecutive
subjects with a suspicion of SAHS (age 50±11 years, 81 % male, BMI 30±4 K/m2) from the
out-patient clinics of three NRC in the Barcelona area: Hospital Asil de Granollers,
Hospital General de Vic and Hospital de Terrassa.
Study design: The patients were evaluated independently, at random, over the course of 1
month in the RC and NRC. In both types of centre, the patient evaluation was carried out on
the basis of the clinical history, with a specific questionnaire about sleep disordered
breathing, and a sleep study in the hospital. The evaluation was performed by a sleep
physician in the RC and by a respiratory physician with training in sleep medicine in the
NRC. In both cases, the choice of treatment was registered on an ordinal scale with four
points: 1= No diagnosis of SAHS and patient is discharged; 2= Mild SAHS, patient should
follow a conservative treatment and clinical control; 3= Moderate to severe SAHS, patient
should begin continuous positive air pressure (CPAP) treatment; 4= Other sleep disorders are
diagnosed (RC), or there is a need for full-night PSG owing to a discordance between
clinical features and respiratory polygraphy in NRC. The indication for CPAP treatment
followed the national-SEPAR guidelines summarized as: 1) Patients with severe SAHS-related
symptoms with an AHI>10; or 2) Patients with mild to moderate clinical symptoms with an
AHI>30. The human ethics committee of our hospital approved the protocol and informed
consent was obtained from all the patients. Sleep studies: Reference hospital: Full-night
polysomnography was performed in the usual manner. Briefly, the variables registered were
electroencephalogram, chin electromyogram, electro-oculogram, tibial electromyogram,
arterial oxygen saturation, ribcage and abdominal motion and their sum. Airflow was measured
by cannula/thermistor. An apnea was defined as the absence or airflow equal to or greater
than 10 seconds. Hypopnoea was defined by any discernible reduction in the amplitude of the
airflow signal ending in an arousal and/or association with a 3% desaturation, with a
duration of at least 10 seconds. An expert technician scored sleep stages and respiratory
variables manually. An apnea-hypopnoea index (AHI) equal to or greater than 10 was
considered abnormal.Non-reference centres: patients received a respiratory poligraphy with
recording of body position, ribcage and abdominal motion, snoring, arterial oxygen
saturation and airflow using a cannula/thermistor. The respiratory physician performed a
manual scoring of the recording. The definitions of hypopnoea and apnea resembled those
mentioned above, except in the case of arousal. Data analysis: Data were entered using SPSS
10.0 and imported to STATA 7.0 to perform the analysis (StatatCorp. 1999. Stata Statistical
software: Release 7.0. College Station, TX: Stata Corporation). Descriptive analysis: Data
were expressed as mean ± SD or percentage for quantitative and qualitative variables,
respectively. For continuum variables, a logarithmic transformation was undertaken to
normalise the distribution, if necessary. If the distribution was not symmetrical, data were
expressed as percentiles. Concordance analysis: Evaluation of the concordance of the final
outcome and the choice of treatment, between the RF and the NFC centres, was performed by
using the statistic Kappa balanced, penalizing extreme discrepancies, following the
classification of Landis & Koch (25). This procedure was also used for the concordance in
the result of the AHI of the sleep study, categorised as follows: <10, 10-29, ≥30.
Concordance in the results of the sleep study (AHI and CT90) was evaluated in accordance
with the Band & Altman methodology and the concordance coefficient of Lin.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05582070 -
Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction
|
N/A | |
Recruiting |
NCT03919955 -
A Novel Pharmacological Therapy for Obstructive Sleep Apnea
|
Phase 2 | |
Completed |
NCT03927547 -
Sleep Disordered Breathing and Cardiopulmonary Disease in Peruvian Highlanders
|
N/A | |
Recruiting |
NCT04007380 -
Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI
|
N/A | |
Completed |
NCT02188498 -
Electrocardiography Data Analysis in Sleep Disorders
|
||
Completed |
NCT01503164 -
Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism
|
N/A | |
Recruiting |
NCT00747890 -
Surgical Treatment of Mild Obstructive Sleep Apnea
|
N/A | |
Active, not recruiting |
NCT00738179 -
Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease
|
Phase 3 | |
Completed |
NCT00841906 -
Alice PDx User/Validation Extended Trial
|
N/A | |
Completed |
NCT00202501 -
Usefulness of Nasal Continuous Positive Airway Pressure (CPAP) Treatment in Patients With a First Ever Stroke and Sleep Apnea Syndrome
|
N/A | |
Completed |
NCT00047463 -
Effects of Treating Obstructive Sleep Apnea in Epilepsy
|
Phase 2 | |
Not yet recruiting |
NCT06029881 -
Portable System for Non-intrusive Monitoring of Sleep
|
||
Recruiting |
NCT06093347 -
Central Apnoea Monitor Study
|
||
Terminated |
NCT05445869 -
Severe OSA Study (SOS)
|
N/A | |
Withdrawn |
NCT04096261 -
The Importance of Sleep Quality and the Blood-brain Barrier in Cognitive Disorders and Alzheimer's Disease
|
||
Recruiting |
NCT04575740 -
Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea
|
N/A | |
Completed |
NCT04676191 -
Validation of a Contactless Vital Signs Measurement Sensor
|
N/A | |
Recruiting |
NCT06015620 -
Comorbidities Resolution After MGB Surgery and Change in Body Composition
|
||
Completed |
NCT06051097 -
Metabolic Syndrome and Obstructive Sleep Apnea
|
||
Completed |
NCT05687097 -
Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury
|